These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29566096)

  • 1. Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model.
    Harris RA; Haberer JE; Musinguzi N; Chang KM; Schechter CB; Doubeni CA; Gross R
    PLoS One; 2018; 13(3):e0194713. PubMed ID: 29566096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.
    Oyugi JH; Byakika-Tusiime J; Ragland K; Laeyendecker O; Mugerwa R; Kityo C; Mugyenyi P; Quinn TC; Bangsberg DR
    AIDS; 2007 May; 21(8):965-71. PubMed ID: 17457090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort.
    Shet A; Kumarasamy N; Poongulali S; Shastri S; Kumar DS; Rewari BB; Arumugam K; Antony J; De Costa A; D'Souza G
    Curr HIV Res; 2016; 14(1):71-9. PubMed ID: 26303008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.
    Haberer JE; Musinguzi N; Boum Y; Siedner MJ; Mocello AR; Hunt PW; Martin JN; Bangsberg DR
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):386-92. PubMed ID: 26110445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.
    Parienti JJ; Das-Douglas M; Massari V; Guzman D; Deeks SG; Verdon R; Bangsberg DR
    PLoS One; 2008 Jul; 3(7):e2783. PubMed ID: 18665246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term health care interruptions among HIV-positive patients in Uganda.
    Mills EJ; Funk A; Kanters S; Kawuma E; Cooper C; Mukasa B; Odit M; Karamagi Y; Mwehire D; Nachega J; Yaya S; Featherstone A; Ford N
    J Acquir Immune Defic Syndr; 2013 May; 63(1):e23-7. PubMed ID: 23406979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
    Orrell C; Cohen K; Leisegang R; Bangsberg DR; Wood R; Maartens G
    AIDS Res Ther; 2017 Apr; 14(1):20. PubMed ID: 28376815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged medically recorded treatment interruptions among HIV-infected patients on highly active antiretroviral therapy with controlled viremia: when physicians have to juggle patient negotiation and guidelines.
    Protopopescu C; Roux P; Carrieri MP; Katlama C; Collin F; Besnier JM; Chêne G; Raffi F; Spire B; Leport C;
    J Acquir Immune Defic Syndr; 2010 Apr; 53(4):544-6. PubMed ID: 20220376
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD.
    Jiamsakul A; Kerr SJ; Ng OT; Lee MP; Chaiwarith R; Yunihastuti E; Van Nguyen K; Pham TT; Kiertiburanakul S; Ditangco R; Saphonn V; Sim BL; Merati TP; Wong W; Kantipong P; Zhang F; Choi JY; Pujari S; Kamarulzaman A; Oka S; Mustafa M; Ratanasuwan W; Petersen B; Law M; Kumarasamy N;
    Trop Med Int Health; 2016 May; 21(5):662-74. PubMed ID: 26950901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods.
    Matthews LT; Ribaudo HB; Kaida A; Bennett K; Musinguzi N; Siedner MJ; Kabakyenga J; Hunt PW; Martin JN; Boum Y; Haberer JE; Bangsberg DR
    J Acquir Immune Defic Syndr; 2016 Apr; 71(4):399-406. PubMed ID: 26495883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Adolescents With Perinatal HIV Infection in Asia.
    Bartlett AW; Lumbiganon P; Kurniati N; Sudjaritruk T; Mohamed TJ; Hansudewechakul R; Ly PS; Truong KH; Puthanakit T; Nguyen LV; Chokephaibulkit K; Do VC; Kumarasamy N; Nik Yusoff NK; Fong MS; Watu DK; Nallusamy R; Sohn AH; Law MG;
    J Adolesc Health; 2019 Nov; 65(5):651-659. PubMed ID: 31395514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to Antiretroviral Therapy in Turkey: Results from the ACTHIV-IST Study Group.
    Yildiz Sevgi D; Gunduz A; Altuntas Aydin O; Mete B; Sargin F; Kumbasar Karaosmanoglu H; Uzun N; Yemisen M; Dokmetas I; Tabak F
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1192-1198. PubMed ID: 28854809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up.
    Knobel H; Urbina O; González A; Sorlí ML; Montero M; Carmona A; Guelar A
    HIV Med; 2009 Jul; 10(6):364-9. PubMed ID: 19490179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random forest machine learning algorithm predicts virologic outcomes among HIV infected adults in Lausanne, Switzerland using electronically monitored combined antiretroviral treatment adherence.
    Kamal S; Urata J; Cavassini M; Liu H; Kouyos R; Bugnon O; Wang W; Schneider MP
    AIDS Care; 2021 Apr; 33(4):530-536. PubMed ID: 32266825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda.
    Musinguzi N; Mocello RA; Boum Y; Hunt PW; Martin JN; Haberer JE; Bangsberg DR; Siedner MJ
    AIDS Behav; 2017 Jun; 21(6):1735-1740. PubMed ID: 27256394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring adherence to antiretroviral therapy in children and adolescents in western Kenya.
    Vreeman RC; Nyandiko WM; Liu H; Tu W; Scanlon ML; Slaven JE; Ayaya SO; Inui TS
    J Int AIDS Soc; 2014; 17(1):19227. PubMed ID: 25427633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    Szubert AJ; Prendergast AJ; Spyer MJ; Musiime V; Musoke P; Bwakura-Dangarembizi M; Nahirya-Ntege P; Thomason MJ; Ndashimye E; Nkanya I; Senfuma O; Mudenge B; Klein N; Gibb DM; Walker AS;
    PLoS Med; 2017 Nov; 14(11):e1002432. PubMed ID: 29136032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America.
    Genberg BL; Wilson IB; Bangsberg DR; Arnsten J; Goggin K; Remien RH; Simoni J; Gross R; Reynolds N; Rosen M; Liu H;
    AIDS; 2012 Jul; 26(11):1415-23. PubMed ID: 22767342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011.
    Martin DA; Luz PM; Lake JE; Clark JL; Veloso VG; Moreira RI; Cardoso SW; Klausner JD; Grinsztejn B
    BMC Infect Dis; 2014 Jun; 14():322. PubMed ID: 24919778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors predicting the failure of interruption of highly active antiretroviral treatment (HAART) in HIV-infected patients].
    Cervero-Jiménez M; Torres-Perea R; Ruiz-Capillas JJ; del Alamo M; Agud JL; Solís J; Bouzas E
    Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):202-7. PubMed ID: 15826544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.